Legend Biotech Corp share price logo

Legend Biotech Corp Share Price

NASDAQ: LEGN

Mid Cap

$18.67

-0.47

(-2.46%)

as on

Legend Biotech Corp Stock Performance

as on April 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $18.64
    $19.33
    downward going graph

    0.16%

    Downside

    3.54%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $16.24
    $45.30
    downward going graph

    13.02%

    Downside

    142.62%

    Upside

    downward going graph

Legend Biotech Corp share price movements today

Previous Close
$19.14
Open
$19.27
Volume
846.8K
Day's Low - High
$18.64 - $19.33
52 Week Low - High
$16.24 - $45.30

Legend Biotech Corp Historical Returns

1 Month Return
+ 0.9 %
3 Month Return
-8.77 %
1 Year Return
-40.21 %
3 Year Return
-62.67 %
5 Year Return
-36.45 %

Legend Biotech Corp Stock Fundamentals & Key Indicators

Check Legend Biotech Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5B

EPS (TTM)

0.062

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-127.1M

Revenue (TTM)

1.0B

Profit Margin

-28.85%

Return On Equity TTM

-29.06%

Legend Biotech Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Legend Biotech Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.5B-36.45%NA-28.85%
BUY$42.3B124.53%136.858.45%
BUY$111.4B103.77%28.6632.94%
NA$35.7BNA126.855.37%
BUY$80.5B59.16%18.3831.41%

Stock Returns calculator for Legend Biotech Corp Stock including INR - Dollar returns

The Legend Biotech Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Legend Biotech Corp investment value today

Current value as on today

₹63,201

Returns

-₹36,799

(-36.8%)

Returns from Legend Biotech Corp Stock

-₹41,674 (-41.67%)

Dollar Impact

₹4,875 (+4.88%)

Analyst Recommendation on Legend Biotech Corp Stock

Based on 27 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Legend Biotech Corp. Average target price of $57.22

Legend Biotech Corp Share Price Target

Get share price movements and forecasts by analysts on Legend Biotech Corp.

What analysts predicted

67.37%UPSIDE

Target Price

$57.22

Current Price

$18.67

Analyzed by

27 Analysts

Target

$57.22

Legend Biotech Corp target price $57.22, a slight upside of 67.37% compared to current price of $18.67. According to 27 analysts rating.

Legend Biotech Corp Stock’s Investor Sentiment and Interest

Search interest for Legend Biotech Corp Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Legend Biotech Corp Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
96
79
93
186
160
186
195
255
272
307
Gross Profit
47
47
39
136
104
112
123
157
157
183
Operating Income
-92
-119
-117
-41
-70
-74
-50
-21
-43
-19
EBITDA
-51
-135
-48
-7
-109
52
-88
-113
-33
-7
Interest Expense
5
5
5
5
5
5
5
5
5
5
Depreciation
5
5
5
5
5
6
5
5
5
11
Income Before Tax
-62
-146
-59
-17
-120
40
-99
-124
-39
-19
Income Tax Expense
0
-1
0
0
4
14
1
0
0
11
Net Income
-62
-144
-59
-18
-125
26
-100
-125
-39
-31
Net Profit Margin
-64.79%
-182.24%
-63.62%
-9.76%
-78.23%
14.09%
-51.74%
-49.16%
-14.57%
-10.09%

Legend Biotech Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
23
49
61
75
68
117
285
627
1,031
Gross Profit
23
49
61
75
68
51
140
392
622
Operating Income
13
-1
-132
-313
-392
-455
-439
-303
-136
EBITDA
14
0
-129
-298
-392
-416
-477
-113
-107
Interest Expense
-
0
0
4
0
10
21
21
21
Depreciation
-
1
5
9
13
18
20
23
28
Income Before Tax
13
-1
-127
-308
-407
-445
-520
-158
-283
Income Tax Expense
4
1
-25
-41
-3
0
-1
18
14
Net Income
9
-2
-101
-266
-403
-446
-518
-177
-297
Net Profit Margin
39.69%
-5.67%
-164.39%
-355.16%
-586.38%
-381.48%
-181.75%
-28.22%
-28.85%

Legend Biotech Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-146
-59
-17
-120
40
-99
-124
-39
-30
Operating Cash Flow
-95
15
-1
-75
-82
-103
-13
28
-105
Investing Cash Flow
407
-396
-695
329
-87
256
-165
-20
640
Financing Cash Flow
0
0
0
4
0
0
0
0
0
Change in Cash
314
-380
-696
258
-172
154
-175
12
622

Legend Biotech Corp Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-130
-308
-407
-445
-520
-158
-297
Operating Cash Flow
307
-83
-223
-198
-201
-393
-144
-100
Investing Cash Flow
-102
-58
-24
-194
-77
92
-850
711
Financing Cash Flow
2
14
618
626
377
791
5
0
Change in Cash
208
-126
372
233
97
491
-990
615

Global Institutional Holdings in Legend Biotech Corp

Funds
Holdings
AllianceBernstein L.P.
0.88%
Matthews International Cap Mgmt LLc
0.56%
BRAIDWELL LP
0.7%
State Street Corp
0.63%
Hillhouse Capital Advisors, Ltd.
3.24%

Legend Biotech Corp News & Key Events

  • img

    Today's Timeline - 12 November

    Wed, 06:02 PM

    -

    Legend Biotech reports Q3 2025 results, highlighting CARVYKTI sales growth and regulatory updates, with a net loss of $39.7 million.

Insights on Legend Biotech Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -125.38M → -31.03M (in $), with an average increase of 121.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 160.20M → 307.63M (in $), with an average increase of 12.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LEGN stock has moved up by 10.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 51.1% return, outperforming this stock by 113.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.3% return, outperforming this stock by 75.5%

About Legend Biotech Corp

legend biotech corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. teamed up with outstanding immunologists and molecular biologists, legend has generated a strong pipeline of chimeric antigen receptor(car) product candidates to treat a wide variety of liquid and solid tumors. our ambition to succeed in the cars field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. by applying one of our proprietary car-t technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. legend biotech corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. we take o
OrganisationLegend Biotech Corp
Headquarters2101 Cottontail Lane, Somerset, NJ, United States, 08873
IndustryCommercial Services
CEODr. Ying Huang Ph.D.
E-voting on sharesClick here to vote

Key Management of Legend Biotech Corp

Name

Title

Surabhi Verma

Manager of Investor Relations & Corporate Communications

Dr. Ying Huang Ph.D.

CEO & Director

Mr. Carlos Santos

Chief Financial Officer

Ms. Ananda Elizabeth Martin Esq., J.D.

Global Compliance Officer

Mr. Birk Vanderweeen

Senior Vice President of Global Manufacturing & Supply

Mr. Alan S. Bash

President of CARVYKTI®

Ms. Jessie Yeung M.B.A.

Vice President of Finance, Investor & Public Relations

Mr. James Pepin J.D.

General Counsel

Dr. Guowei Fang Ph.D.

President of Research & Development

Ms. Joanne Choi

Senior Manager of Investor Relations

FAQs

What is Legend Biotech Corp share price today?

Legend Biotech Corp share price today is $18.67 as on at the close of the market. Legend Biotech Corp share today touched a day high of $19.33 and a low of $18.64.

What is the 52 week high and 52 week low for Legend Biotech Corp share?

Legend Biotech Corp share touched a 52 week high of $45.3 on and a 52 week low of $16.24 on . Legend Biotech Corp stock price today i.e. is closed at $18.67,which is 58.78% down from its 52 week high and 14.96% up from its 52 week low.

What is Legend Biotech Corp's market capitalisation today?

Legend Biotech Corp market capitalisation is $0.00T as on .

How to invest in Legend Biotech Corp Stock (LEGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Legend Biotech Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Legend Biotech Corp Shares that will get you 0.0803 shares as per Legend Biotech Corp share price of $18.67 per share as on April 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Legend Biotech Corp Stock (LEGN) from India?

Indian investors can start investing in Legend Biotech Corp (LEGN) shares with as little as ₹93.06 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.60 in Legend Biotech Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Legend Biotech Corp share’s latest price of $18.67 as on April 7, 2026 at 1:29 am IST, you will get 0.5356 shares of Legend Biotech Corp. Learn more about fractional shares .

What are the returns that Legend Biotech Corp has given to Indian investors in the last 5 years?

Legend Biotech Corp stock has given -36.45% share price returns and 26.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?